Postural orthostatic tachycardia syndrome
Not recruitingStudy on the Effectiveness of Human Normal Immunoglobulin for Adults with Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)
Study on the Effectiveness of Human Normal Immunoglobulin for Adults with Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)
- Disease:Postural orthostatic tachycardia syndrome
- Substances:Human Plasma ProteinHuman Normal Immunoglobulin
Spain- Participants:18–64 years · 65+ years
- Substances:Human Plasma Protein
- Sponsor:CSL Behring LLC












